Product
AN4005
Aliases
AN4005-dose level 0, AN4005-dose level 1, AN4005-dose level 2, AN4005-dose level 3, AN4005-dose level 4 (1 other aliases)
1 clinical trial
2 indications
Indication
Advanced Solid TumorIndication
LymphomaClinical trial
Clinical Study Protocol AN4005X0101 An Open-Label, Multicenter, Phase 1 Study of AN4005 in Patients With Advanced TumorsStatus: Recruiting, Estimated PCD: 2024-05-01